Medtronic announced Friday that FDA has approved the the first MR-conditional cardiac resynchronization therapy defibrillators (CRT-Ds) for the treatment of heart failure in the U.S. The Medtronic ...
Please provide your email address to receive an email when new articles are posted on . Among the features of the new European Society of Cardiology guideline on pacing and cardiac resynchronization ...
“This new device platform provides a number of new features that will help me to improve management of my patients with ICD and CRT-D devices, while delivering new safety features on top of St. Jude ...
PLATINIUM, released simultaneously in both Europe and Japan by LivaNova (formerly Sorin Group), will protect patients from avoidable replacement surgeries and the inherent risk of complications.
ST. PAUL, MINN. - St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval and first U.S. implants of its Unifyâ„¢ cardiac re ...
DUBLIN and BARCELONA, Two real-world analyses featuring the Medtronic plc (NYSE: MDT) AdaptivCRT(TM) algorithm reinforce that its use is linked to a reduction in atrial fibrillation (AF) episodes, as ...
"Increasing the longevity of ICD and CRT-D devices is crucial for patients to avoid early replacement surgeries, which carry risks of complications and increase the cost of care," said Dr. Steven ...
MINNEAPOLIS & BOSTON--(BUSINESS WIRE)-- Medtronic, Inc. (NYSE: MDT) today announced findings from an economic analysis of the landmark RAFT (Resynchronization / Defibrillation in Ambulatory Heart ...
A manufacturing defect that prevents delivery of necessary electrical shocks has resulted in the recall of four dozen already-implanted cardiac resynchronization therapy-defibrillation (CRT-D) devices ...
San Francisco, CA - When a heart-failure patient has a defibrillator-equipped cardiac resynchronization therapy (CRT-D) device, antitachycardia pacing (ATP) is preferable to a shock for the treatment ...